Alpha-v beta-3 integrin expression in normal and atherosclerotic artery

Area of Science:

• Cardiovascular Biology
• Integrin Signaling
• Atherosclerosis Research

Background:

• Alpha v beta 3 integrin is implicated in atherosclerosis and restenosis, influencing smooth muscle cell migration and angiogenesis.
• While alpha v beta 3 ligands are present in atherosclerotic plaques, its expression at these sites remains largely uncharacterized.

Purpose of the Study:

• To investigate the expression patterns of alpha v beta 3 integrin in normal and atherosclerotic human coronary arteries.
• To determine the cellular localization of alpha v beta 3 integrin within different arterial layers and plaque components.

Main Methods:

• Immunohistochemical analysis of 36 coronary artery segments from heart transplant recipients, categorized as diffuse intimal thickening (DIT) or atherosclerotic plaques.
• Utilized monoclonal antibodies against alpha v beta 3 and cell markers for smooth muscle cells (SMCs), macrophages, and endothelial cells.
• Confirmed alpha v beta 3 presence in aortic media via immunoprecipitation and RT-PCR.

Main Results:

• High alpha v beta 3 integrin expression observed on the endothelium of both DIT and plaque arteries.
• Extensive, though less intense, alpha v beta 3 expression found in the media of both artery types.
• Intimal alpha v beta 3 expression predominantly colocalized with SMCs, with minimal association with macrophages; plaque microvessels showed prominent expression.

Conclusions:

• Alpha v beta 3 integrin is widely expressed in human coronary arteries, including atherosclerotic lesions.
• Its localization on endothelial cells, smooth muscle cells, and plaque neovasculature suggests a significant role in atherosclerosis pathogenesis.
• Further research into alpha v beta 3 integrin's function in vascular disease is warranted.